Ceredex Value Advisors LLC Merck & Co., Inc. Transaction History

Ceredex Value Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $43.3 Million - $51 Million	-628,162 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$71.77 - $79.65 $33.7 Million - $37.4 Million	-469,846 Reduced 42.79%	628,162 $51.8 Million
Q3 2020 Nov 09, 2020	SELL	$73.18 - $82.95 $15.8 Million - $17.9 Million	-216,029 Reduced 16.44%	1,098,008 $91.8 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $92.5 Million - $105 Million	1,314,037 New	1,314,037 $102 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Ceredex Value Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ceredex Value Advisors LLC with notifications on news.